🔴 LifeMD is trading 5.3% down today as catalyst remains uncertain

LifeMD is trading 5.3% down at $3.22, with no clear company-specific catalyst identified for the September 16, 2026 decline.

• The September 15 AT&T collaboration offers complimentary memberships to eligible customers and initially reaches approximately 29 million customers, making it a positive strategic development rather than an obvious explanation for the drop.
• Broader indices are generally higher; market direction does not clearly explain the underperformance, and delayed company news may require monitoring.